Fig. 2From: Transferrin predicts trimethylamine-N-oxide levels and is a potential biomarker of cardiovascular diseasePercentage reductions in odds ratios, (1-OR) × 100%, with 95% confidence intervals, for higher versus lower TMAO levels at successively higher quartiles of transferrin. The interquartile range of transferrin was 243 mg/dL (25th percentile) to 300 mg/dL (75th percentile) with a median of 273 mg/dL (50th percentile)Back to article page